Microsoft Word - BSR-PI Corporate Water Strategies Trends Report--FINAL--Sep 4 2007 At the Crest of a Wave: A Proactive Approach to Corporate Water Strategy September 2007…
QbD implementation in Generic Industry: Are we there yet? Inna Ben-Anat, Director, Global QbD and Product Robustness, Teva Pharmaceuticals Jan 2015 Generic…
1. GDUFA Regulatory Science Update Robert Lionberger, Ph.D. Director Office of Research and Standards Office of Generic Drugs Center for Drug Evaluation and Research, FDA…
Slide 1Potential Impact on Data Exclusivity: A Necessary Form of IP in a FOB World Susan Finston, President “Biosimilars and Follow-On Biologics” Doubletree Hotel, Crystal…
Slide 1 Pharmaceuticals and Global Health: Successes, Challenges and Outlook 19. July 2013, University of Sussex Thomas B. Cueni, Secretary General Interpharma Association…
Hazardous waste: Whatâs so âSpecialâ? Mark Heggie Waste Policy Unit [email protected] Regulatory framework What is it, how is it regulated and what are our duties/responsibilities…